CAS RN: 51716-62-2
Spiro[1,3-dioxolane-2,2′(1’H)-pentalen]-5′(3’H)-one, tetrahydro-, (3’aR,6’aS)-rel-
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 51716-62-2
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Shanghai
Inquiry
51716-62-2 / (3aR,6aS)-spiro[1,3,3a,4,6,6a-hexahydropentalene-5,2'-1,3-dioxolane]-2-one
Standard CAS: 51716-62-2
Multi CAS: Yes
Basic Information
copy
CAS
51716-62-2 copy
Multi CAS
Yes copy
Molecular Formula
C10H14O3 copy
Molecular Weight
182.220000 copy
Exact Mass
182.094294 copy
InChI
InChI=1S/C10H14O3/c11-9-3-7-5-10(6-8(7)4-9)12-1-2-13-10/h7-8H,1-6H2/t7-,8+ copy
InChIKey
WWAYLSXXLXIQNN-OCAPTIKFSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
13 copy
Fraction Csp3
0.9 copy
H-bond acceptors
3 copy
Molar refractivity
45.09 copy
TPSA
35.53 copy
LogP / Solubility
WLOGP
1.12 copy
MLOGP
0.98 copy
XLogP3
0.1 copy
Consensus LogP
0.73 copy
Log S (ESOL)
-1.67 copy
Class (ESOL)
Soluble copy
Log S (Ali)
-1.86 copy
Class (Ali)
Soluble copy
Log S (SILICOS-IT)
-1.77 copy
Class (SILICOS-IT)
Soluble copy
ADME
GI absorption
High copy
BBB permeant
Yes copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-3.04 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
3.5 copy